Abu Dhabi’s Mubadala Investment Company would invest in Rodenstock Group, a manufacturer of premium ophthalmic lenses. Rodenstock has been a leader in prescription lenses for over 140 years, since its inception in 1877. Headquartered in Munich, Germany, Rodenstock employs around 4,900 people worldwide and is represented by sales subsidiaries and distribution partners in more than 85 countries. The company has a strong portfolio of innovative technologies – its patented “DNEye Pro” technology enabled Rodenstock to become the first company to measure the individual shape and size of each eye using thousands of data points. The technology allows the company to produce individualized eyeglass lenses, called Biometric Intelligent Glasses. The company’s portfolio also includes eyewear under the Rodenstock and Porsche Design brands.
Rodenstock is the leading pure play lens manufacturer in the European market, with a strong reputation for innovation and a consistent focus on offering a differentiated customer proposition. Mubadala will work in partnership with Apax to support the Rodenstock management team’s vision of accelerating the company’s growth through innovation, commercial execution and digitization, whilst continuing to deliver the highest level of service to clients and partners. The transaction is subject to applicable regulatory approvals and is expected to close in the middle of 2021.